One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Merck & Co.
Posted inCOVID-19, Infections, Research
Omicron Treatment: Most Effective Drugs
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Posted inCOVID-19, Infections, Regulatory
Paxlovid for COVID-19 Treatment. All Details
Paxlovid: treatment efficacy, “Paxlovid mouth”, COVID-19 rebound, management of Omicron variant, treatment resistance, generics, mechanism of action, price.
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.
Posted inNew Drugs, Oncology, Regulatory
Tivdak: New Drug for Cervical Cancer
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Posted inOncology, Research
Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.